Results 111 to 120 of about 36,868 (221)

Acalculous Cholecystitis: The Unexpected Mask of De Novo Heart Failure

Clinical Case Reports
Acute acalculous cholecystitis refers to inflammation of the gallbladder without the presence of gallstones or obstruction of the cystic duct. Heart failure is recognized for causing congestive hepatopathy and can lead to gallbladder swelling, often ...
Mhd Baraa Habib, Maram Albandak, Mhd Husam Osman, Shahem Abbarh, Bisher Sawaf, Yaseen Alastal, Abdulrahman Arabi   +6 more
doaj   +1 more source

Rapidly Progressive Retroperitoneal Dissemination of Plasmacytoid Urothelial Carcinoma Presenting With Multiorgan Obstruction After Radical Cystectomy: A Case Report

IJU Case Reports, Volume 9, Issue 5, September 2026.
ABSTRACT Introduction Plasmacytoid urothelial carcinoma (PUC) is a rare, aggressive subtype of bladder cancer characterized by diffuse infiltrative growth and a propensity for peritoneal and retroperitoneal dissemination. Case Presentation A patient with muscle‐invasive bladder cancer (cT3N1M0) was diagnosed with conventional high‐grade urothelial ...
Mahito Atsuta, Naoki Uchida, Hirokazu Kagawa, Naoya Tomomasa, Shun Saito, Kazuhiro Takahashi, Kosuke Iwatani, Shun Sato, Takahiro Kimura, Jun Miki   +9 more
wiley   +1 more source

The Evolution of Medications for Obesity Management

JGH Open, Volume 10, Issue 9, September 2026.
ABSTRACT This narrative review provides an overview of progress in the development of obesity medications, including a synthesis of data describing the efficacy and safety of currently available agents and emerging therapeutic options. Historically, many obesity medications have been withdrawn from the market due to safety concerns.
Jaskirath Gill, Priya Sumithran
wiley   +1 more source

When Enzymes Mislead: Assessing the Value of MRCP in Suspected Choledocholithiasis

ANZ Journal of Surgery, Volume 96, Issue 9, Page 2513-2521, September 2026.
ABSTRACT Background The diagnosis of choledocholithiasis (CDL) requires balancing timely intervention against the risks of unnecessary invasive procedures. Although liver function tests (LFTs) are widely used for risk stratification, their static values and short‐term trends remain poorly defined in predicting persistent common bile duct stones.
Renato Pitesa, Wai Yan (Rachel) Yuen, Nadia Meyer, Garth Poole, Primal Parry Singh   +4 more
wiley   +1 more source

Diagnostic Guidelines for the Evaluation of Choledocholithiasis in Patients With Acute Biliary Presentations: A Study of Their Applicability and Feasibility in a Publicly Funded Healthcare System

ANZ Journal of Surgery, Volume 96, Issue 9, Page 2522-2530, September 2026.
ABSTRACT Background The American and European Societies of Gastrointestinal Endoscopy (ASGE and ESGE) have published diagnostic guidelines for the evaluation of choledocholithiasis. The applicability and feasibility of these guidelines in a publicly funded health care system, such as ours in Aotearoa New Zealand, are not known. This retrospective study
Henry C. K. Kwok, Alain C. Vandal, Andrew G. Hill, Andrew D. MacCormick   +3 more
wiley   +1 more source

Endoscopic Papillectomy May Be a Feasible Treatment Option for Elderly Patients With Ampullary Tumors: A Multicenter Retrospective Study

Digestive Endoscopy, Volume 38, Issue 9, September 2026.
Multicenter retrospective analysis of 255 patients undergoing endoscopic papillectomy demonstrated significantly lower rates of delayed bleeding and post‐EP pancreatitis in patients aged ≥ 75 years. Age ≥ 75 75 years was independently associated with reduced risks of both adverse events, while serious complications, complete resection, and recurrence ...
Noriki Kasuga, Yusuke Kurita, Yusuke Sekino, Keiki Nagai, Yuji Fujita, Riko Hemmi, Daiki Imanaga, Manato Kaneda, Shota Matsumoto, Masato Suzuki, Shin Yagi, Kensuke Kubota, Masato Yoneda   +12 more
wiley   +1 more source

Hepatic Safety of Orforglipron in Adults With Obesity or Overweight and/or Type 2 Diabetes: A Pooled Analysis of the Orforglipron Phase 3 Clinical Trials

Diabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 8347-8358, September 2026.
ABSTRACT Aims Orforglipron is a novel small‐molecule, once daily oral non‐peptide GLP‐1 receptor agonist. The hepatic safety profile in adults with obesity or overweight and/or type 2 diabetes (T2D) across seven orforglipron Phase 3 clinical trials was assessed.
Sean Wharton, Adam Stefanski, Jiaxun Chen, Girish Rao, Elvis Asare Twum, Max Denning   +5 more
wiley   +1 more source

Hemorrhagic Cholecystitis [PDF]

Radiology, 2018
Víctor, López, Felipe, Alconchel
openaire   +2 more sources

Amylin Analogs: The Next Major Class of Weight Loss Therapy: A Review of Experimental Data and Early‐Phase Clinical Trials

Diabetes, Obesity and Metabolism, Volume 28, Issue S5, Page 42-50, September 2026.
ABSTRACT Aims The management of the disease of obesity has been transformed by incretin‐based therapies; however, additional and alternative therapeutic strategies are needed to address its biological complexity. This narrative review examines the physiology of amylin and the emerging role of amylin‐based therapies in obesity management.
Abdulhameed Alhazmi, Carel W. le Roux
wiley   +1 more source

Emergency Cholecystectomy for Gangrenous Acute Cholecystitis with Profound Thrombocytopenia: Immune Thrombocytopenia Diagnosed Postoperatively. [PDF]

Surg Case Rep
Tokumaru T, Tabuchi M, Uemura S, Tamura S, Iriyoshi H, Imai T, Kakizaki M, Osawa S, Okabayashi T.   +8 more
europepmc   +1 more source